7" (18cm) Appx 0.31 ml, Smallbore Ext Set w/Remv MicroClave® Clear, NanoClave T-Connector, Clamp, Rotating Luer. 1 unit per pouch, 50 multivac pouches per case. UDI:(01)10887709051055(17)250101(30)50(10)4590834; (01)10887709051055(17)250101(30)50(10)4557481; (01)10887709051055(17)241201(30)50(10)4536601; (01)10887709051055(17)250201(30)50(10)4724818; (01)10887709051055(17)250201(30)50(10)4733548. The Intravascular Administration Set is a single use, sterile, non-pyrogenic device which provides access for the administration of fluids from a container to a patient's vascular system through the administration set's needle or catheter (which is inserted into a vein).
Published October 28, 2020 · Recall initiated: July 6, 2020
Summary
FDA records medical device Class II recall Z-0187-2021, published October 28, 2020 and initiated July 6, 2020. Recalling firm: ICU Medical, Inc.; Status: Terminated; Reported quantity: Total of all products (Listed #1 thru 101) = 304735 units; Lot: Lot Numbers:4590834, 4557481, 4536601, 4724818, 4733548. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Identification of a potential manufacturing defect on the internal surface of the NanoClave within specific lots of NanoClave sets, which may inhibit a proper seal with the NanoClave spike.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- ICU Medical, Inc.
- Distributor
- Worldwide Distribution: US (nationwide): AL, AZ, CA, CO, DE, FL,GA,ID, IL,IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NH,NJ,NM,NV, NY, OH, OK, OR, PA,RI, TN, TX, UT, VA, WA, WI, and WV; and OUS countries of: Belgium, Brazil, Canada, France, Germany, Ireland, Japan, Martinique, Mexico, Poland, and Saudi Arabia.
- Lot
- Lot Numbers:4590834, 4557481, 4536601, 4724818, 4733548.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAIV Sets with drip chambersSeptember 23, 2026
- FDAIV Sets with drip chambersSeptember 23, 2026
- FDAOncology sets with drip chambersSeptember 23, 2026
- FDAIV Non-Dedicated Gravity Administration Sets with drip chambersSeptember 23, 2026
- FDA7" (18 cm) Appx 0.29 ml, Smallbore Ext Set w/MicroClave Clear, NanoClave, Clamp, Rotating Luer; 1 unit perOctober 28, 2020
- FDA6.5" (17 cm) Appx 0.30 ml, Smallbore Pressure Infusion (400psig) Ext Set w/Remv MicroClave, NanoClaveOctober 28, 2020
Questions about this recall
Was 7" (18cm) Appx 0.31 ml, Smallbore Ext Set w/Remv MicroClave® Clear, NanoClave T-Connector, Clamp, Rotating Luer. 1 unit per pouch, 50 multivac pouches per case. UDI:(01)10887709051055(17)250101(30)50(10)4590834; (01)10887709051055(17)250101(30)50(10)4557481; (01)10887709051055(17)241201(30)50(10)4536601; (01)10887709051055(17)250201(30)50(10)4724818; (01)10887709051055(17)250201(30)50(10)4733548. The Intravascular Administration Set is a single use, sterile, non-pyrogenic device which provides access for the administration of fluids from a container to a patient's vascular system through the administration set's needle or catheter (which is inserted into a vein). recalled?
Yes. FDA published recall Z-0187-2021 on October 28, 2020. Reported hazard: Identification of a potential manufacturing defect on the internal surface of the NanoClave within specific lots of NanoClave sets, which may inhibit a proper seal with the NanoClave spike.
What should I do if I have this product?
Voluntary: Firm initiated · Letter